Skip to Main Content

Paper Details

Use of Statins and Outcomes in Intracerebral Hemorrhage Patients.
Stroke
30
2017
Intracerebral Hemorrhage, Patients, Statin, Statins, disability, hematoma, intracerebral hemorrhage, patient, patients, statin, statins
Author NameAffiliation
Carl D LangefeldSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Carl D LangefeldSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Charles J MoomawSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Jonathan RosandSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Jonathan RosandSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Christiana E HallSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
Daniel WooSouthern Illinois University School of Medicine, Springfield (F.M.S.) Center for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, University of Cincinnati, D.W.) Center for Genomic Medicine, Massachusetts General Hospital, University of Arizona, Tucson (C.S.K.) Michael E. DeBakey VA Medical Center and Department of Neurology, Baylor College of Medicine, University of Texas Southwestern Medical Center
  • 1 - 7

Datasets